Skip to content
Screener

Core Scientific, Inc. CORZ Cash & Equivalents

Cash & Equivalents at other companies

CleanSpark logo
CleanSparkCLSK
$202.6M+486%
TeraWulf logo
TeraWulfWULF
$3.03B+3,213%
Equinix, Inc. logo
Equinix, Inc.EQIX
$1.02B-72.5%
Applied Digital logo
Applied DigitalAPLD
$1.59B+1,191%
Digital Realty logo
Digital RealtyDLR
$3.45B-10.8%
Marathon Digital Holdings logo
Marathon Digital HoldingsMARA
$433.27M+257%

Other financials

Income statement

See full
Revenue$164.2M+109%
Gross profit$70.0M+1,294%
Operating income-$78.5M-199%
Net income-$1.2B-23.3%
EPS (diluted)-$3.32-8,200%

Balance sheet

See full
Total debt$4.4B+279%
Total equity-$2.4B-127%
Total assets$5.3B+166%

Cash flow

See full
Operating cash flow$249.9M+715%
CapEx$565.0M+366%
Free cash flow-$583.9M-569%

Valuation

See full
Market cap$7B+63.3%
Enterprise value$8.85B+81.9%
P/S15.9×+3.6×

Profitability

See full
Gross margin28.3%+23.2pp
Operating margin-128.5%-362pp
Net margin-237.6%-3.1pp
FCF margin-217.5%-446pp

Returns & leverage

See full
Return on equity148.5%
Debt / equity2.2×
Current ratio0.9×-0.9×

Where this comes from

Reported directly by Core Scientific, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The source filing: Core Scientific, Inc.’s 10-Q, filed July 28, 2026.

Filed
Jul 28, 2026, 7:08 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001839341-26-000014
Line itemSix Months Ended June 30, 2026Six Months Ended June 30, 2025
Net cash provided by (used in) financing activities3,191,955(35,970)
Net increase (decrease) in cash, cash equivalents and restricted cash2,240,013(255,635)
Cash, cash equivalents and restricted cash—beginning of period311,378836,980
Cash, cash equivalents and restricted cash—end of period$2,551,391$581,345
Supplemental disclosure of other cash flow information:
Cash paid for interest, net of capitalized interest$12,846$8,386
Income tax payments$652$457
Supplemental disclosure of non-cash investing and financing activities:

Item 1. Financial Statements (Unaudited)

FAQ

What is Core Scientific, Inc.'s cash & equivalents?
Core Scientific, Inc. (CORZ) reported cash & equivalents of $2.55B in Q2 2026.
How has Core Scientific, Inc.'s cash & equivalents changed year-over-year?
Core Scientific, Inc.'s cash & equivalents increased by 338.9% year-over-year, from $581.35M to $2.55B.
What is the long-term trend for Core Scientific, Inc.'s cash & equivalents?
Over 4 years (2021 to 2025), Core Scientific, Inc.'s cash & equivalents has grown at a 323.2% compound annual growth rate (CAGR), from $970.88K to $311.38M.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.

Ask your AI about Core Scientific, Inc.'s cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude